A randomized, intraindividual, non-inferiority, Phase III study comparing daylight photodynamic therapy with BF-200 ALA gel and MAL cream for the treatment of actinic keratosis.

J Eur Acad Dermatol Venereol · 2019 · PMC6585804 · PMID 30022544

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

highly significantno p-value reported

The P ‐value of the subordinate one‐sided Wilcoxon signed rank test was P < 0.0001, confirming highly significant non‐inferiority.

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.